HC Wainwright & Co. Maintains Buy on Aura Biosciences, Raises Price Target to $22

Benzinga · 10/18 10:24
HC Wainwright & Co. analyst Edward White maintains Aura Biosciences (NASDAQ:AURA) with a Buy and raises the price target from $21 to $22.